Who are Alesta's investors?

Alesta's investors include Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, Frazier Healthcare Partners, RTW Investments L.P., Thuja Capital.

Alesta

Founded 2021 · 21 employees on LinkedIn · 6 known investors

Find your way into Alesta

154 people in our graph share verified history with the Alesta team — schools, employers, funds. One of them is your warm intro.

Simon Woutersunlockedknows Matthias Van Woensel · together at KU Leuven (overlapped)

×10knows the team · via KU Leuven

knows the team · via Università degli Studi di Perugia

Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology. The biotech company works on early-stage drug development and clinical research.

Biotech Healthtech

Founders & leadership

Ilan GanotinCEO

Benit MaruCMO

Matthias Van Woensel inCSOPartner at Droia Ventures

Investors · 6

Droia VenturesLeuven · $540K

Frazier Life SciencesPalo Alto

Novartis Venture FundBasel · $5M – $25M

Frazier Healthcare PartnersreportedSeattle · $50M – $400M

RTW Investments L.P.reportedNew York

Thuja CapitalreportedUtrecht

In the news

Etched's $21b valuation, Smack's battlefield software, and Goldman's real estate buyaxios.com · Aug 2026

Frequently asked questions

What does Alesta do?: Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology. The biotech company works on early-stage drug development and clinical research.
Who are Alesta's investors?: Alesta's investors include Droia Ventures, Frazier Life Sciences, Novartis Venture Fund, Frazier Healthcare Partners, RTW Investments L.P., Thuja Capital.